Future use of genomics in coronary artery disease.

Coronary artery disease (CAD) remains the number one cause of death in industrialized countries despite our collective efforts to minimize attributable risk from known contributors to CAD such as hypertension, dyslipidemia, and smoking. In addition, clinical trials have consistently demonstrated a family history of coronary disease to be predictive for future cardiovascular events beyond that which would be explained by traditional risk factors. These findings support and have prompted widespread investigation into the genomic basis of CAD and myocardial infarction (MI). Recent advances in genotyping technology have allowed for easier identification and confirmation of susceptibility genes for complex traits across different cohorts via increased power of studies stemming from faster accrual of cases and control subjects and more precise genetic mapping. These technological advances have resulted in defining the genes contributing to a substantial or even majority of population-attributable risk for type 2 diabetes and age-related macular degeneration (AMD) cases. Similar progress in replicating novel susceptibility genes for CAD and specifically MI is now rapidly occurring, with a recent gene marker on chromosome 9p21 representing a highly significant and common variant susceptibility factor. With improved resequencing technology and better phenotypic characterization of our CAD cases and control subjects, we should achieve successes in gene identification and confirmation similar to diabetes and AMD, thereby allowing us to better quantify CAD risk earlier in life and institute more effective therapy reducing the individual propensity to develop CAD.

[1]  Alexander Pertsemlidis,et al.  Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9 , 2005, Nature Genetics.

[2]  Eric Boerwinkle,et al.  Sequence Variations in PCSK 9 , Low LDL , and Protection against Coronary Heart Disease , 2006 .

[3]  K. Bussell.  Signalling: Friendly rivalry , 2005, Nature Reviews Molecular Cell Biology.

[4]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[5]  Jonathan C. Cohen,et al.  A Common Allele on Chromosome 9 Associated with Coronary Heart Disease , 2007, Science.

[6]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[7]  M Freedman,et al.  Single Nucleotide Polymorphisms in Multiple Novel Thrombospondin Genes May Be Associated With Familial Premature Myocardial Infarction , 2001, Circulation.

[8]  Yun Li,et al.  CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration , 2006, Nature Genetics.

[9]  Silke Schmidt,et al.  A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. , 2004, American journal of human genetics.

[10]  Judy H Cho,et al.  Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis , 2007, Nature Genetics.

[11]  H. Izawa,et al.  Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. , 2002 .

[12]  Thomas Lengauer,et al.  A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 , 2007, Nature Genetics.

[13]  J. Gulcher,et al.  A variant in CDKAL1 influences insulin response and risk of type 2 diabetes , 2007, Nature Genetics.

[14]  S. Mane,et al.  LRP 6 Mutation in a Family with Early Coronary Disease and Metabolic Risk Factors , 2008 .

[15]  S Shea,et al.  Family history as an independent risk factor for coronary artery disease. , 1984, Journal of the American College of Cardiology.

[16]  H. Stefánsson,et al.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes , 2006, Nature Genetics.

[17]  E. Topol,et al.  Replication of the association between the thrombospondin-4 A387P polymorphism and myocardial infarction. , 2004, American heart journal.

[18]  Hiroshi Sato,et al.  Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction , 2002, Nature Genetics.

[19]  E. Topol,et al.  Mutation of MEF2A in an Inherited Disorder with Features of Coronary Artery Disease , 2003, Science.

[20]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Haines,et al.  Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease. , 2007, American journal of human genetics.

[22]  E. Topol,et al.  Gene Variants of VAMP8 and HNRPUL1 Are Associated With Early-Onset Myocardial Infarction , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[23]  Mario J. Garcia,et al.  Challenges in the phenotypic characterisation of patients in genetic studies of coronary artery disease , 2006, Journal of Medical Genetics.

[24]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[25]  Jonathan C. Cohen,et al.  Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. , 2006, The New England journal of medicine.

[26]  Jurg Ott,et al.  Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. , 2005, American journal of human genetics.

[27]  Meir J Stampfer,et al.  Meta-Analysis: Apolipoprotein E Genotypes and Risk for Coronary Heart Disease , 2004, Annals of Internal Medicine.

[28]  M. McCarthy,et al.  Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes , 2007, Science.

[29]  Jayaram Radhakrishnan,et al.  LRP6 Mutation in a Family with Early Coronary Disease and Metabolic Risk Factors , 2007, Science.

[30]  Marta E Alarcón-Riquelme,et al.  A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus , 2006, Nature Genetics.

[31]  A. Gylfason,et al.  A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction , 2007, Science.

[32]  Jonathan C. Cohen,et al.  Lack of MEF2A mutations in coronary artery disease. , 2005, The Journal of clinical investigation.

[33]  Yusuke Nakamura,et al.  Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro , 2004, Nature.

[34]  A. Edwards,et al.  Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.

[35]  Inês Barroso,et al.  TCF7L2 Polymorphisms Modulate Proinsulin Levels and β-Cell Function in a British Europid Population , 2007, Diabetes.

[36]  Y. Ohnishi,et al.  Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction , 2003, Nature Genetics.

[37]  M. Daly,et al.  Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. , 2000, American journal of human genetics.

[38]  J. Pulido,et al.  Relationship between age-related macular degeneration-associated variants of complement factor H and LOC387715 with coronary artery disease. , 2007, Mayo Clinic proceedings.

[39]  C. Dina,et al.  A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27. , 2001, Human molecular genetics.

[40]  T. Cohnert,et al.  Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Whittemore,et al.  Multiple regions within 8q24 independently affect risk for prostate cancer , 2007, Nature Genetics.

[42]  A. Zwinderman,et al.  Thrombospondin-2 Polymorphism Is Associated With a Reduced Risk of Premature Myocardial Infarction , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[43]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[44]  D. Levy,et al.  Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. , 2001, Atherosclerosis.

[45]  Per Eriksson,et al.  Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility , 2005, Nature Genetics.

[46]  Jonathan C. Cohen,et al.  Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol , 2004, Science.

[47]  Johanna M Seddon,et al.  Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration , 2006, Nature Genetics.

[48]  Lisa J. Martin,et al.  A comprehensive linkage analysis for myocardial infarction and its related risk factors , 2002, Nature Genetics.

[49]  Eric J Topol,et al.  Premature myocardial infarction novel susceptibility locus on chromosome 1P34-36 identified by genomewide linkage analysis. , 2004, American journal of human genetics.

[50]  Martin Farrall,et al.  Genetic susceptibility to coronary artery disease: from promise to progress , 2006, Nature Reviews Genetics.

[51]  Jan Hillert,et al.  MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction , 2005, Nature Genetics.

[52]  E. Topol,et al.  Transcription factor MEF2A mutations in patients with coronary artery disease. , 2004, Human molecular genetics.

[53]  M. Daly,et al.  Genome-wide association studies for common diseases and complex traits , 2005, Nature Reviews Genetics.

[54]  Elizabeth R Hauser,et al.  GATA2 Is Associated with Familial Early-Onset Coronary Artery Disease , 2006, PLoS genetics.

[55]  A. Hofman,et al.  A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study. , 2006, Journal of the American College of Cardiology.

[56]  P. Fearnhead,et al.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007, Nature Genetics.

[57]  E. Topol.  Cholesterol, racial variation and targeted medicines , 2005, Nature Medicine.

[58]  C. Dina,et al.  A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16 p 13 and replicates linkage with the metabolic syndrome on 3 q 27 , 2001 .

[59]  Jonathan C. Cohen,et al.  Miscues on the “ lack of MEF 2 A mutations ” in coronary artery disease , 2005 .

[60]  Jonathan C. Cohen,et al.  A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol. , 2006, American journal of human genetics.

[61]  J. Gulcher,et al.  The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke , 2004, Nature Genetics.

[62]  O. Faergeman,et al.  The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction : a substudy of the Scandinavian simvastatin survival study. , 2000, Circulation.

[63]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[64]  B. Rosner,et al.  Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. , 2007, JAMA.

[65]  E. Topol,et al.  Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes , 2004, Journal of Medical Genetics.

[66]  A. Tonkin,et al.  Genome-Wide Linkage Analysis of the Acute Coronary Syndrome Suggests a Locus on Chromosome 2 , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[67]  John Danesh,et al.  Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66 155 cases and 91 307 controls , 2006, The Lancet.

[68]  P. Burton,et al.  A genomewide linkage study of 1,933 families affected by premature coronary artery disease: The British Heart Foundation (BHF) Family Heart Study. , 2005, American journal of human genetics.

[69]  A. Rissanen.  Familial occurrence of coronary heart disease: effect of age at diagnosis. , 1979, The American journal of cardiology.

[70]  G. Abecasis,et al.  A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants , 2007, Science.

[71]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[72]  Harlan M Krumholz,et al.  Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. , 2007, JAMA.

[73]  T. Hudson,et al.  A genome-wide association study identifies novel risk loci for type 2 diabetes , 2007, Nature.

[74]  Eric Boerwinkle,et al.  Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL , 2007, Nature Genetics.

[75]  A. Roses,et al.  The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective. , 1997, JAMA.

[76]  Marcia M. Nizzari,et al.  Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels , 2007, Science.

[77]  Vilmundur Gudnason,et al.  A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction , 2006, Nature Genetics.

[78]  Timothy B. Stockwell,et al.  The Sequence of the Human Genome , 2001, Science.

[79]  P. Libby,et al.  Atherosclerosis: the path from genomics to therapeutics. , 2007, Journal of the American College of Cardiology.

[80]  G. Abecasis,et al.  Strong Association of the Y 402 H Variant in Complement Factor H at 1 q 32 with Susceptibility to Age-Related Macular Degeneration , 2005 .

[81]  E. Ros,et al.  Preclinical coronary atherosclerosis in a population with low incidence of myocardial infarction: cross sectional autopsy study , 2003, BMJ : British Medical Journal.

[82]  E. Topol,et al.  Miscues on the "lack of MEF2A mutations" in coronary artery disease. , 2005, The Journal of clinical investigation.

[83]  L. Palmer,et al.  Genomewide scans of complex human diseases: true linkage is hard to find. , 2001, American journal of human genetics.

[84]  D. Gudbjartsson,et al.  Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial. , 2005, JAMA.

[85]  Christopher B. Miller,et al.  Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.

[86]  D. Gudbjartsson,et al.  Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24 , 2007, Nature Genetics.